Alice Schuch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alice Schuch has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Louise Torres
Department of Radiology, Hospital Moinhos de Vento, Rua Ramiro Barcelos 910, Porto Alegre, RS, 90560-032, Brazil
3 shared publications - Mário Reis Álvares-Da-Silva
Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
3 shared publications - Caroline Lorenzoni Almeida Ghezzi
Department of Radiology, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil
2 shared publications - Fernando Morbeck Almeida Coelho
Department of Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
2 shared publications - Gabriela Carboni
Hospital Moinhos de Vento
2 shared publications - Gabriela Carboni
Department of Radiology, Hospital Moinhos de Vento, Porto Alegre, Brazil.
2 shared publications
Latest Publications
- 1 July 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (7) , e250236
Invited Commentary: Three-Piece Inflatable Penile Prosthesis: Imaging Insights Beyond the Operating Room
- 1 July 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (7) , e250236
Invited Commentary: Three-Piece Inflatable Penile Prosthesis: Imaging Insights Beyond the Operating Room
- 15 April 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (10) , 4997-5011
MRI risk stratification in metabolic dysfunction–associated steatotic liver disease (MASLD): from diffuse liver disease to focal lesions
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. Hepatic steatosis, its imaging hallmark, is a frequent incidental finding in abdominal imaging, often prompting further clinical evaluation. Despite this, the integration of imaging-derived biomarkers into structured risk stratification pathways and longitudinal disease management remains inconsistent in clinical practice. This narrative review outlines the role of multiparametric magnetic resonance imaging (MRI) in the assessment of MASLD, focusing on clinically actionable applications for abdominal radiology. Quantitative MRI biomarkers - including proton density fat fraction (MRI-PDFF), magnetic resonance elastography (MRE), R2* iron quantification, and gadoxetic acid-enhanced MRI - provide complementary information for evaluation of steatosis, fibrosis, iron overload, hepatocellular function, and focal liver lesions. The contribution of multiparametric MRI to opportunistic disease detection, identification of clinically significant fibrosis, and longitudinal monitoring of disease progression and therapeutic response is summarized. Key imaging pitfalls in steatotic livers are addressed, including altered lesion conspicuity, heterogeneous fat and stiffness distribution, focal stiffness abnormalities, and diagnostic challenges related to hepatocellular carcinoma in non-cirrhotic MASLD. Multiparametric MRI enables comprehensive, noninvasive, whole-liver evaluation of MASLD and supports imaging-informed risk stratification and longitudinal disease management in abdominal radiology practice.
- 15 April 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (10) , 4997-5011
MRI risk stratification in metabolic dysfunction–associated steatotic liver disease (MASLD): from diffuse liver disease to focal lesions
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. Hepatic steatosis, its imaging hallmark, is a frequent incidental finding in abdominal imaging, often prompting further clinical evaluation. Despite this, the integration of imaging-derived biomarkers into structured risk stratification pathways and longitudinal disease management remains inconsistent in clinical practice. This narrative review outlines the role of multiparametric magnetic resonance imaging (MRI) in the assessment of MASLD, focusing on clinically actionable applications for abdominal radiology. Quantitative MRI biomarkers - including proton density fat fraction (MRI-PDFF), magnetic resonance elastography (MRE), R2* iron quantification, and gadoxetic acid-enhanced MRI - provide complementary information for evaluation of steatosis, fibrosis, iron overload, hepatocellular function, and focal liver lesions. The contribution of multiparametric MRI to opportunistic disease detection, identification of clinically significant fibrosis, and longitudinal monitoring of disease progression and therapeutic response is summarized. Key imaging pitfalls in steatotic livers are addressed, including altered lesion conspicuity, heterogeneous fat and stiffness distribution, focal stiffness abnormalities, and diagnostic challenges related to hepatocellular carcinoma in non-cirrhotic MASLD. Multiparametric MRI enables comprehensive, noninvasive, whole-liver evaluation of MASLD and supports imaging-informed risk stratification and longitudinal disease management in abdominal radiology practice.
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (1) , e253364
Steatosis, Diabetes, and Fibrosis: Bridging Quantitative MRI and Clinical Scores in MASLD
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (1) , e253364
Steatosis, Diabetes, and Fibrosis: Bridging Quantitative MRI and Clinical Scores in MASLD
- 23 February 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-15
Imaging of intrauterine contraceptive devices: a comprehensive pictorial review
Intrauterine contraceptive devices (IUCDs) are widely used, highly effective, and reversible methods of contraception. Despite their overall safety profile, IUCD malposition and complications May occur and are frequently asymptomatic or clinically unsuspected, posing a diagnostic challenge in daily practice. Imaging plays a central role in evaluating IUCD location, integrity, and associated complications, often in patients undergoing ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) for unrelated indications. Familiarity with the different types of IUCDs and their expected imaging appearances is essential for accurate interpretation. Proper positioning requires complete intrauterine placement with fundal orientation, while deviations May represent a spectrum of malposition, including expulsion, displacement, embedment, and uterine perforation. Additional complications such as fragmentation, missing retrieval strings, pelvic inflammatory disease, actinomycosis, and pregnancy with an IUCD in situ further broaden the differential diagnosis. Recognition of key imaging features and common diagnostic pitfalls is critical, as some findings warrant prompt clinical communication and intervention. Integrating this knowledge into routine imaging assessment enhances diagnostic accuracy, supports appropriate clinical management, and reduces the risk of overlooked IUCD-related complications
- 23 February 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-15
Imaging of intrauterine contraceptive devices: a comprehensive pictorial review
Intrauterine contraceptive devices (IUCDs) are widely used, highly effective, and reversible methods of contraception. Despite their overall safety profile, IUCD malposition and complications May occur and are frequently asymptomatic or clinically unsuspected, posing a diagnostic challenge in daily practice. Imaging plays a central role in evaluating IUCD location, integrity, and associated complications, often in patients undergoing ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) for unrelated indications. Familiarity with the different types of IUCDs and their expected imaging appearances is essential for accurate interpretation. Proper positioning requires complete intrauterine placement with fundal orientation, while deviations May represent a spectrum of malposition, including expulsion, displacement, embedment, and uterine perforation. Additional complications such as fragmentation, missing retrieval strings, pelvic inflammatory disease, actinomycosis, and pregnancy with an IUCD in situ further broaden the differential diagnosis. Recognition of key imaging features and common diagnostic pitfalls is critical, as some findings warrant prompt clinical communication and intervention. Integrating this knowledge into routine imaging assessment enhances diagnostic accuracy, supports appropriate clinical management, and reduces the risk of overlooked IUCD-related complications
- Open Access
- 1 January 2026
- Published by Tikinet Edicao Ltda. - EPP in Clinical and Biomedical Research
- Vol. 46
Avaliação sequencial da fibrose hepática na era da nomenclatura MASLD
- 1 January 2026
- Published by Tikinet Edicao Ltda. - EPP in Clinical and Biomedical Research
- Vol. 46
Open AccessAvaliação sequencial da fibrose hepática na era da nomenclatura MASLD
- 1 January 2026
- Published by Tikinet Edicao Ltda. - EPP in Clinical and Biomedical Research
- Vol. 46
Torção de Apêndice Epiploico do Ligamento Falciforme
- 1 January 2026
- Published by Tikinet Edicao Ltda. - EPP in Clinical and Biomedical Research
- Vol. 46
Torção de Apêndice Epiploico do Ligamento Falciforme
- 27 June 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (1) , 223-237
Advances in prostate cancer imaging: from detection to post-treatment
Advancements in prostate imaging, particularly multiparametric magnetic resonance imaging (mpMRI), have transformed the diagnosis and monitoring paradigms for prostate cancer (PCa). However, considerable interobserver variability has been reported,emphasizing the importance of standardized scoring and reporting systems. The Prostate Imaging Reporting and Data System (PI-RADS), along with quality assurance protocols such as Prostate Imaging Quality (PI-QUAL), has enhanced the diagnostic accuracy of mpMRI. While mpMRI effectively identifies extraprostatic extension, emerging hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) and radio labeled prostate-specific membrane antigen (PSMA) tracers have improved metastasis detection. In active surveillance settings, the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation (PRECISE) recommendations enable the assessment of longitudinal PCa changes. Post-treatment evaluation can also employ dedicated frameworks, such as the Prostate Imaging for Recurrence Reporting (PI-RR) after radical prostatectomy, and either the Prostate Imaging after Focal Ablation (PI-FAB) or the Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET). This article reviews key aspects of mpMRI, including structured interpretation frameworks beyond the widely recognized PI-RADS.
- 27 June 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (1) , 223-237
Advances in prostate cancer imaging: from detection to post-treatment
Advancements in prostate imaging, particularly multiparametric magnetic resonance imaging (mpMRI), have transformed the diagnosis and monitoring paradigms for prostate cancer (PCa). However, considerable interobserver variability has been reported,emphasizing the importance of standardized scoring and reporting systems. The Prostate Imaging Reporting and Data System (PI-RADS), along with quality assurance protocols such as Prostate Imaging Quality (PI-QUAL), has enhanced the diagnostic accuracy of mpMRI. While mpMRI effectively identifies extraprostatic extension, emerging hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) and radio labeled prostate-specific membrane antigen (PSMA) tracers have improved metastasis detection. In active surveillance settings, the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation (PRECISE) recommendations enable the assessment of longitudinal PCa changes. Post-treatment evaluation can also employ dedicated frameworks, such as the Prostate Imaging for Recurrence Reporting (PI-RR) after radical prostatectomy, and either the Prostate Imaging after Focal Ablation (PI-FAB) or the Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET). This article reviews key aspects of mpMRI, including structured interpretation frameworks beyond the widely recognized PI-RADS.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e20240073
Patologias não neoplásicas e neoplásicas da bolsa testicular na ressonância magnética: um ensaio iconográfico
Resumo A ressonância magnética é uma ferramenta importante na avaliação da bolsa testicular em casos com achados inconclusivos pela ultrassonografia. A capacidade da ressonância magnética de diferenciar entre lesões intratesticulares e extratesticulares, bem como entre condições neoplásicas e não neoplásicas, tem papel crucial na caracterização de lesões, no estadiamento de tumores e auxilia na decisão pré-operatória. Este ensaio apresenta imagens de ressonância magnética que destacam as principais patologias não neoplásicas e neoplásicas. O reconhecimento dessas patologias reforça o papel do médico radiologista na linha de cuidado de pacientes com lesões da bolsa testicular mediante uma avaliação adequada das suas características de imagem.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e20240073
Open AccessPatologias não neoplásicas e neoplásicas da bolsa testicular na ressonância magnética: um ensaio iconográfico
Resumo A ressonância magnética é uma ferramenta importante na avaliação da bolsa testicular em casos com achados inconclusivos pela ultrassonografia. A capacidade da ressonância magnética de diferenciar entre lesões intratesticulares e extratesticulares, bem como entre condições neoplásicas e não neoplásicas, tem papel crucial na caracterização de lesões, no estadiamento de tumores e auxilia na decisão pré-operatória. Este ensaio apresenta imagens de ressonância magnética que destacam as principais patologias não neoplásicas e neoplásicas. O reconhecimento dessas patologias reforça o papel do médico radiologista na linha de cuidado de pacientes com lesões da bolsa testicular mediante uma avaliação adequada das suas características de imagem.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e20240073
Non-neoplastic and neoplastic scrotal pathologies on magnetic resonance imaging: a pictorial essay
Magnetic resonance imaging is an essential tool for the assessment of the scrotum, particularly in cases with inconclusive ultrasound findings. It has a great capacity to differentiate between intratesticular and extratesticular lesions, as well as between neoplastic and non-neoplastic lesions. By providing an accurate characterization of lesions, magnetic resonance imaging plays a crucial role in preoperative tumor staging and decision-making. This pictorial essay highlights the key non-neoplastic and neoplastic testicular pathologies, as evaluated by magnetic resonance imaging. The recognition of these pathologies underscores the role the radiologists play in the care of patients with scrotal lesions, by providing an appropriate evaluation of the relevant imaging characteristics.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e20240073
Open AccessNon-neoplastic and neoplastic scrotal pathologies on magnetic resonance imaging: a pictorial essay
Magnetic resonance imaging is an essential tool for the assessment of the scrotum, particularly in cases with inconclusive ultrasound findings. It has a great capacity to differentiate between intratesticular and extratesticular lesions, as well as between neoplastic and non-neoplastic lesions. By providing an accurate characterization of lesions, magnetic resonance imaging plays a crucial role in preoperative tumor staging and decision-making. This pictorial essay highlights the key non-neoplastic and neoplastic testicular pathologies, as evaluated by magnetic resonance imaging. The recognition of these pathologies underscores the role the radiologists play in the care of patients with scrotal lesions, by providing an appropriate evaluation of the relevant imaging characteristics.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e4en
Metástases para linfonodos inguinais no câncer de próstata: um novo olhar sobre um padrão incomum de disseminação
O câncer de próstata é a segunda neoplasia mais comum em homens, atrás apenas do câncer de pele não melanoma(1 1 Gandaglia G, Abdollah F, Schiffmann J, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014;74:210–6. ). A disseminação metastática do câncer de próstata ocorre por invasão local, disseminação linfática e hematogênica, sendo os linfonodos pélvicos e os ossos os sítios mais comuns, encontrados em 99% e 84% dos casos, respectivamente(2 2 Swanson GP, Hubbard JK. A better understanding of lymphatic drainage of the prostate with modern imaging and surgical techniques. Clin Genitourin Cancer. 2013;11:431–40. ). A dúvida referente ao comprometimento de linfonodos inguinais surgiu principalmente com a maior utilização de métodos de imagens seccionais como a TC e a RM, e também pela avaliação metabólica por PET, especialmente com radiofármacos específicos para câncer de próstata, como o PSMA. As metástases para linfonodos inguinais são consideradas raras e representam um desafio diagnóstico por não serem incluídas nos campos de tratamento convencionais de radioterapia ou linfadenectomia. A real prevalência e os fatores preditivos para linfonodos inguinais metastáticos permanecem incertos, com a literatura existente baseada em achados de imagem, sem correlação histopatológica(3 3 Jackson ASN, Sohaib SA, Staffurth JN, et al. Distribution of lymph nodes in men with prostatic adenocarcinoma and lymphadenopathy at presentation: a retrospective radiological review and implications for prostate and pelvis radiotherapy. Clin Oncol (R Coll Radiol). 2006;18:109–16. ,4 4 Schiller K, Stöhrer L, Düsberg M, et al. PSMA-PET/CT-based lymph node atlas for prostate cancer patients recurring after primary treatment: clinical implications for salvage radiation therapy. Eur Urol Oncol. 2021;4:73–83. ).
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e4en
Open AccessMetástases para linfonodos inguinais no câncer de próstata: um novo olhar sobre um padrão incomum de disseminação
O câncer de próstata é a segunda neoplasia mais comum em homens, atrás apenas do câncer de pele não melanoma(1 1 Gandaglia G, Abdollah F, Schiffmann J, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014;74:210–6. ). A disseminação metastática do câncer de próstata ocorre por invasão local, disseminação linfática e hematogênica, sendo os linfonodos pélvicos e os ossos os sítios mais comuns, encontrados em 99% e 84% dos casos, respectivamente(2 2 Swanson GP, Hubbard JK. A better understanding of lymphatic drainage of the prostate with modern imaging and surgical techniques. Clin Genitourin Cancer. 2013;11:431–40. ). A dúvida referente ao comprometimento de linfonodos inguinais surgiu principalmente com a maior utilização de métodos de imagens seccionais como a TC e a RM, e também pela avaliação metabólica por PET, especialmente com radiofármacos específicos para câncer de próstata, como o PSMA. As metástases para linfonodos inguinais são consideradas raras e representam um desafio diagnóstico por não serem incluídas nos campos de tratamento convencionais de radioterapia ou linfadenectomia. A real prevalência e os fatores preditivos para linfonodos inguinais metastáticos permanecem incertos, com a literatura existente baseada em achados de imagem, sem correlação histopatológica(3 3 Jackson ASN, Sohaib SA, Staffurth JN, et al. Distribution of lymph nodes in men with prostatic adenocarcinoma and lymphadenopathy at presentation: a retrospective radiological review and implications for prostate and pelvis radiotherapy. Clin Oncol (R Coll Radiol). 2006;18:109–16. ,4 4 Schiller K, Stöhrer L, Düsberg M, et al. PSMA-PET/CT-based lymph node atlas for prostate cancer patients recurring after primary treatment: clinical implications for salvage radiation therapy. Eur Urol Oncol. 2021;4:73–83. ).